247 related articles for article (PubMed ID: 17609380)
1. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
[TBL] [Abstract][Full Text] [Related]
2. β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.
Park EJ; Min KJ; Lee TJ; Yoo YH; Kim YS; Kwon TK
Cell Death Dis; 2014 May; 5(5):e1230. PubMed ID: 24832602
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer.
Chang MC; Mahar R; McLeod MA; Giacalone AG; Huang X; Boothman DA; Merritt ME
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893874
[TBL] [Abstract][Full Text] [Related]
4. β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation.
Zhao W; Jiang L; Fang T; Fang F; Liu Y; Zhao Y; You Y; Zhou H; Su X; Wang J; Liu S; Chen Y; Wan J; Huang X
Front Oncol; 2021; 11():747282. PubMed ID: 34676172
[TBL] [Abstract][Full Text] [Related]
5. Following anticancer drug activity in cell lysates with DNA devices.
Kahanda D; Singh N; Boothman DA; Slinker JD
Biosens Bioelectron; 2018 Nov; 119():1-9. PubMed ID: 30098460
[TBL] [Abstract][Full Text] [Related]
6. Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB.
Dong GZ; Oh ET; Lee H; Park MT; Song CW; Park HJ
Exp Mol Med; 2010 May; 42(5):327-34. PubMed ID: 20200474
[TBL] [Abstract][Full Text] [Related]
7. β-lapachone regulates mammalian inositol pyrophosphate levels in an NQO1- and oxygen-dependent manner.
Eisenbeis VB; Qiu D; Gorka O; Strotmann L; Liu G; Prucker I; Su XB; Wilson MSC; Ritter K; Loenarz C; Groß O; Saiardi A; Jessen HJ
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2306868120. PubMed ID: 37579180
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.
Calahorra J; Blaya-Cánovas JL; Castellini-Pérez O; Aparicio-Puerta E; Cives-Losada C; Marin JJG; Rementeria M; Cara FE; López-Tejada A; Griñán-Lisón C; Aulicino F; Berger I; Marchal JA; Delgado-Almenta V; Granados-Principal S
Biomed Pharmacother; 2024 May; 174():116439. PubMed ID: 38518601
[TBL] [Abstract][Full Text] [Related]
9. Implications of NQO1 in cancer therapy.
Oh ET; Park HJ
BMB Rep; 2015 Nov; 48(11):609-17. PubMed ID: 26424559
[TBL] [Abstract][Full Text] [Related]
10. β-Lapachone, an NQO1 bioactivatable drug, prevents lung tumorigenesis in mice.
Chen Y; Wu R; Li X; Cao M; Yang M; Fu B; Xuan C; Chen C; Zhou Y; Hu R
Eur J Pharmacol; 2024 Jun; 973():176511. PubMed ID: 38604545
[TBL] [Abstract][Full Text] [Related]
11. Redox modulation of NQO1.
Siegel D; Dehn DD; Bokatzian SS; Quinn K; Backos DS; Di Francesco A; Bernier M; Reisdorph N; de Cabo R; Ross D
PLoS One; 2018; 13(1):e0190717. PubMed ID: 29298345
[TBL] [Abstract][Full Text] [Related]
12. Measuring NQO1 Bioactivation Using [
Mahar R; Chang MC; Merritt ME
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439319
[TBL] [Abstract][Full Text] [Related]
13. Augmented Concentration of Isopentyl-Deoxynyboquinone in Tumors Selectively Kills NAD(P)H Quinone Oxidoreductase 1-Positive Cancer Cells through Programmed Necrotic and Apoptotic Mechanisms.
Wang J; Su X; Jiang L; Boudreau MW; Chatkewitz LE; Kilgore JA; Zahid KR; Williams NS; Chen Y; Liu S; Hergenrother PJ; Huang X
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136388
[TBL] [Abstract][Full Text] [Related]
14. Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.
Ma X; Huang X; Huang G; Li L; Wang Y; Luo X; Boothman DA; Gao J
Adv Healthc Mater; 2014 Aug; 3(8):1210-6. PubMed ID: 24532286
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8
Jiang ZB; Xu C; Wang W; Zhang YZ; Huang JM; Xie YJ; Wang QQ; Fan XX; Yao XJ; Xie C; Wang XR; Yan PY; Ma YP; Wu QB; Leung EL
Pharmacol Res; 2021 Jul; 169():105656. PubMed ID: 33964470
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Potential and Safety Profile of β-Lapachone In Vitro.
Lima KMM; Calandrini de Azevedo LF; Rissino JD; Vale VV; Costa EVS; Dolabela MF; Nagamachi CY; Pieczarka JC
Molecules; 2024 Mar; 29(6):. PubMed ID: 38543031
[TBL] [Abstract][Full Text] [Related]
17. IP-DNQ induces mitochondrial dysfunction and G2/M phase cell cycle arrest to selectively kill NQO1-positive pancreatic cancer cells.
Jiang L; Liu Y; Tumbath S; Boudreau MW; Chatkewitz LE; Wang J; Su X; Zahid KR; Li K; Chen Y; Yang K; Hergenrother PJ; Huang X
Antioxid Redox Signal; 2023 Nov; ():. PubMed ID: 37950707
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.
Tsao YC; Chang YJ; Wang CH; Chen L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575541
[TBL] [Abstract][Full Text] [Related]
19. Single-Cell Kinetic Modeling of β-Lapachone Metabolism in Head and Neck Squamous Cell Carcinoma.
Raddatz AD; Furdui CM; Bey EA; Kemp ML
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978989
[TBL] [Abstract][Full Text] [Related]
20. Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-Lapachone delivery.
Zhou Y; Dong Y; Huang G; Wang Y; Huang X; Zhang F; Boothman DA; Gao J; Liang W
J Mater Chem B; 2016 Dec; 4(46):7429-7440. PubMed ID: 28580145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
